---
figid: PMC6168336__nihms-1500072-f0006
figlink: /pmc/articles/PMC6168336/figure/F6/
number: F6
caption: In this illustration, potential mechanisms of tumor cell survival via crosstalk
  between components of the MET pathway, glycolysis, and autophagy are depicted. Basal
  levels of autophagy are typically low through mTOR inhibition of ULK1, a key enzyme
  in upregulation of autophagy, and glycolysis predominates as the main mechanism
  for ATP generation. Aberrant MET activation leads to upregulation of downstream
  effectors including components of the PI3K/AKT/mTOR pathway and glycolytic metabolism
  is maintained. Through blockade of MET and subsequent indirect activation of ULK1
  through the absence of negative feedback with mTOR inhibition, upregulation in autophagy
  occurs to maintain cellular homeostasis. A simplified canonical pathway of autophagy
  (steps 1–4) are shown.
pmcid: PMC6168336
papertitle: Cabozantinib exhibits potent antitumor activity in colorectal cancer patient-derived
  tumor xenograft models via autophagy and signaling mechanisms.
reftext: Aaron J Scott, et al. Mol Cancer Ther. 2018 Oct;17(10):2112-2122.
pmc_ranked_result_index: '31777'
pathway_score: 0.9587954
filename: nihms-1500072-f0006.jpg
figtitle: In this illustration, potential mechanisms of tumor cell survival via crosstalk
  between components of the MET pathway, glycolysis, and autophagy are depicted
year: '2018'
organisms: Homo sapiens
ndex: 09bf7727-dede-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6168336__nihms-1500072-f0006.html
  '@type': Dataset
  description: In this illustration, potential mechanisms of tumor cell survival via
    crosstalk between components of the MET pathway, glycolysis, and autophagy are
    depicted. Basal levels of autophagy are typically low through mTOR inhibition
    of ULK1, a key enzyme in upregulation of autophagy, and glycolysis predominates
    as the main mechanism for ATP generation. Aberrant MET activation leads to upregulation
    of downstream effectors including components of the PI3K/AKT/mTOR pathway and
    glycolytic metabolism is maintained. Through blockade of MET and subsequent indirect
    activation of ULK1 through the absence of negative feedback with mTOR inhibition,
    upregulation in autophagy occurs to maintain cellular homeostasis. A simplified
    canonical pathway of autophagy (steps 1–4) are shown.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATG3
  - AKT3
  - AKT1
  - AKT2
  - HGF
  - MAP1LC3A
  - AXL
  - PIK3R3
  - PIK3R4
  - PIK3CA
  - MFAP1
  - PIK3R5
  - MET
  - MTOR
  - PIK3CB
  - PIK3CG
  - PIK3CD
  - KDR
  - TEK
  - PIK3R6
  - Glucose
  - AMP
  - Pyruvate
  - Acetyl-CoA
  - TCA
  - Cancer
genes:
- word: ATG3
  symbol: ATG3
  source: hgnc_symbol
  hgnc_symbol: ATG3
  entrez: '64422'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: LC3
  symbol: LC3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP1LC3A
  entrez: '84557'
- word: AXL
  symbol: AXL
  source: hgnc_symbol
  hgnc_symbol: AXL
  entrez: '558'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: TIE2
  symbol: TIE-2
  source: hgnc_alias_symbol
  hgnc_symbol: TEK
  entrez: '7010'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: AMP
  source: MESH
  identifier: D000249
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: TCA
  source: MESH
  identifier: C000589078
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6168336__F6
redirect_from: /figures/PMC6168336__F6
figtype: Figure
---
